HT
ABBV icon

Headlands Technologies’s AbbVie ABBV Stock Holding History

Headlands Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
+13,821
New +$2.97M 0.37% 66
2025
Q4 		– Sell
-3,472
Closed -$804K – 655
2025
Q3 		$804K Sell
3,472
-5,340
-61% -$1.09M 0.06% 277
2025
Q2 		$1.64M Buy
8,812
+6,174
+234% +$1.15M 0.2% 110
2025
Q1 		$553K Buy
+2,638
New +$513K 0.06% 274
2024
Q2 		– Sell
-1,551
Closed -$282K – 1105
2024
Q1 		$282K Sell
1,551
-1,819
-54% -$313K 0.07% 299
2023
Q4 		$522K Buy
+3,370
New +$491K 0.16% 128
2023
Q1 		– Sell
-113
Closed -$18K – 490
2022
Q4 		$18K Buy
+113
New +$17.3K 0.01% 324

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Headlands Technologies's ABBV Position: Q2 2026 in Review

Headlands Technologies opened a new position in AbbVie (ABBV) in Q2 2026: 13,821 shares worth $3.48M. The stake represents 0.37% of the portfolio and ranks #66 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in ABBV as recently as Q3 2025.

Headlands Technologies first reported a position in ABBV in Q4 2022 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Headlands Technologies held 13,821 shares of AbbVie worth $3.48M as of Q2 2026.
  • AbbVie was a new Headlands Technologies position in Q2 2026.
  • AbbVie made up 0.37% of Headlands Technologies's portfolio in Q2 2026, its #66 holding.
  • Headlands Technologies first reported a position in AbbVie in Q4 2022 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.